What is the main business of Cefea?

The main business activity of Cefea focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 26, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Działkowa 56, 02-234 Warszawa.

Who is on the management board?

The management board consists of: Daniel Gralak (Member of the Management Board) and Marcin Paweł Nielepkowicz (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.

What was the revenue?

The company reported a revenue of $295 in 2018.

No, in 2018 the company was not profitable, reporting a net loss of $851.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $885 in 2018, representing 77% of all operating expenses.

Cefeasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-04-26

Share capital

50 000,00 PLN

Activity description

Cefea is a dynamic organization that provides a wide range of services for the pharmaceutical sector, including repackaging of medications, medical products, and dietary supplements. The company also offers comprehensive support for clinical trials, including manufacturing, blinding, and logistics, as well as import solutions for non-EU companies entering the EU market. Additionally, Cefea supplies high-quality raw materials for the cosmetic, food, and pharmaceutical industries.

Registered address

ul. Działkowa 56, 02-234 Warszawa, Poland

Website

cefea.pl

Phone

Financials

The financial statement for 2019 has not yet been filed with the Financial Document Repository (past deadline).

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2018.

Results vs industry

Revenue

This companyUSD 294.66MedianUSD 816.16kAverageUSD 29.28m

Net profit

This companyUSD -851.06MedianUSD 8.96kAverageUSD 2.64m

Operating costs

This companyUSD 1.15kMedianUSD 701.47kAverageUSD 19.26m

Assets

This companyUSD 31.81kMedianUSD 800.13kAverageUSD 29.34m

Industry

Bank accounts

Was a VAT taxpayer from 2018-12-01 to 2021-09-06. Removed from VAT register

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Daniel Gralak — Management Board Member

Marcin Paweł Nielepkowicz — Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Daniel Gralak (50)	25	$6,753.11	50%
Marcin Paweł Nielepkowicz (51)	25	$6,753.11	50%

Beneficial owners

Person	Rights
Daniel Gralak (50)	Shareholder of a limited liability company, 25000.0 PLN
Marcin Nielepkowicz (51)	Shareholder of a limited liability company, 25000.0 PLN

Competitors

	Name	Revenue	Website
	Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com

Change history

Date	Event
2018-02-15	Address change (Ul. Wiktorii Wiedeńskiej 9a/42, 02-954, Warszawa → Ul. Działkowa 56, 02-234, Warszawa)
2016-04-26	Entered in the register

FAQ

Last updated: 2026-04-17